Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-19-013072
Filing Date
2019-06-07
Accepted
2019-06-07 16:50:38
Documents
1
Period of Report
2019-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4043
  Complete submission text file 0001567619-19-013072.txt   5465
Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Mahatme Sandesh (Reporting) CIK: 0001511034 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37722 | Film No.: 19886573

Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Issuer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations